145 related articles for article (PubMed ID: 7578114)
1. How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium.
Abraham DJ; Safo MK; Boyiri T; Danso-Danquah RE; Kister J; Poyart C
Biochemistry; 1995 Nov; 34(46):15006-20. PubMed ID: 7578114
[TBL] [Abstract][Full Text] [Related]
2. Bisaldehyde allosteric effectors as molecular ratchets and probes.
Boyiri T; Safo MK; Danso-Danquah RE; Kister J; Poyart C; Abraham DJ
Biochemistry; 1995 Nov; 34(46):15021-36. PubMed ID: 7578115
[TBL] [Abstract][Full Text] [Related]
3. Control of the allosteric equilibrium of hemoglobin by cross-linking agents.
Marden MC; Cabanes-Macheteau M; Babes A; Kiger L; Griffon N; Poyart C; Boyiri T; Safo MK; Abraham DJ
Protein Sci; 2002 Jun; 11(6):1376-83. PubMed ID: 12021436
[TBL] [Abstract][Full Text] [Related]
4. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats.
Abraham DJ; Wireko FC; Randad RS; Poyart C; Kister J; Bohn B; Liard JF; Kunert MP
Biochemistry; 1992 Sep; 31(38):9141-9. PubMed ID: 1390701
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
[TBL] [Abstract][Full Text] [Related]
6. Allosteric effectors do not alter the oxygen affinity of hemoglobin crystals.
Mozzarelli A; Rivetti C; Rossi GL; Eaton WA; Henry ER
Protein Sci; 1997 Feb; 6(2):484-9. PubMed ID: 9041656
[TBL] [Abstract][Full Text] [Related]
7. Magnesium(II) and zinc(II)-protoporphyrin IX's stabilize the lowest oxygen affinity state of human hemoglobin even more strongly than deoxyheme.
Miyazaki G; Morimoto H; Yun KM; Park SY; Nakagawa A; Minagawa H; Shibayama N
J Mol Biol; 1999 Oct; 292(5):1121-36. PubMed ID: 10512707
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of T state haemoglobin with oxygen bound at all four haems.
Paoli M; Liddington R; Tame J; Wilkinson A; Dodson G
J Mol Biol; 1996 Mar; 256(4):775-92. PubMed ID: 8642597
[TBL] [Abstract][Full Text] [Related]
9. Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.
Pagare PP; Ghatge MS; Musayev FN; Deshpande TM; Chen Q; Braxton C; Kim S; Venitz J; Zhang Y; Abdulmalik O; Safo MK
Bioorg Med Chem; 2018 May; 26(9):2530-2538. PubMed ID: 29655608
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic evidence for a new ensemble of ligand-induced allosteric transitions in hemoglobin: the T-to-T(high) quaternary transitions.
Kavanaugh JS; Rogers PH; Arnone A
Biochemistry; 2005 Apr; 44(16):6101-21. PubMed ID: 15835899
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of bar-headed goose hemoglobin in deoxy form: the allosteric mechanism of a hemoglobin species with high oxygen affinity.
Liang Y; Hua Z; Liang X; Xu Q; Lu G
J Mol Biol; 2001 Oct; 313(1):123-37. PubMed ID: 11601851
[TBL] [Abstract][Full Text] [Related]
12. Insights into the solution structure of human deoxyhemoglobin in the absence and presence of an allosteric effector.
Sahu SC; Simplaceanu V; Gong Q; Ho NT; Tian F; Prestegard JH; Ho C
Biochemistry; 2007 Sep; 46(35):9973-80. PubMed ID: 17691822
[TBL] [Abstract][Full Text] [Related]
13. T-quaternary structure of oxy human adult hemoglobin in the presence of two allosteric effectors, L35 and IHP.
Kanaori K; Tajiri Y; Tsuneshige A; Ishigami I; Ogura T; Tajima K; Neya S; Yonetani T
Biochim Biophys Acta; 2011 Oct; 1807(10):1253-61. PubMed ID: 21703224
[TBL] [Abstract][Full Text] [Related]
14. Capturing the hemoglobin allosteric transition in a single crystal form.
Shibayama N; Sugiyama K; Tame JR; Park SY
J Am Chem Soc; 2014 Apr; 136(13):5097-105. PubMed ID: 24635037
[TBL] [Abstract][Full Text] [Related]
15. Direct observation of conformational population shifts in crystalline human hemoglobin.
Shibayama N; Ohki M; Tame JRH; Park SY
J Biol Chem; 2017 Nov; 292(44):18258-18269. PubMed ID: 28931607
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.
Randad RS; Mahran MA; Mehanna AS; Abraham DJ
J Med Chem; 1991 Feb; 34(2):752-7. PubMed ID: 1995897
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic activity at the molecular level: E. J. Ariëns' concept visualized.
Abraham DJ; Kister J; Joshi GS; Marden MC; Poyart C
J Mol Biol; 1995 May; 248(4):845-55. PubMed ID: 7752245
[TBL] [Abstract][Full Text] [Related]
18. Properties of a recombinant human hemoglobin with aspartic acid 99(beta), an important intersubunit contact site, substituted by lysine.
Yanase H; Cahill S; Martin de Llano JJ; Manning LR; Schneider K; Chait BT; Vandegriff KD; Winslow RM; Manning JM
Protein Sci; 1994 Aug; 3(8):1213-23. PubMed ID: 7987216
[TBL] [Abstract][Full Text] [Related]
19. Pyridyl derivatives of benzaldehyde as potential antisickling agents.
Nnamani IN; Joshi GS; Danso-Danquah R; Abdulmalik O; Asakura T; Abraham DJ; Safo MK
Chem Biodivers; 2008 Sep; 5(9):1762-9. PubMed ID: 18816529
[TBL] [Abstract][Full Text] [Related]
20. X-ray diffraction study of the binding of the antisickling agent 12C79 to human hemoglobin.
Wireko FC; Abraham DJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2209-11. PubMed ID: 2006159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
